Literature DB >> 33772567

Non-specific oral and cutaneous manifestations of Coronavirus Disease 2019 in children.

E Bardellini1, M-P Bondioni, F Amadori, F Veneri, V Lougaris, A Meini, A Plebani, A Majorana.   

Abstract

BACKGROUND: Coronavirus Disease 2019 (COVID-19) seems to affect children only marginally, as a result, there is less knowledge of its manifestations in childhood. The purpose of this retrospective cross-sectional study was to investigate the oral and cutaneous manifestations in children affected by COVID-19.
MATERIAL AND METHODS: All the medical records of children with COVID-19 admitted to the Pediatric Clinic- ASST Spedali Civili of Brescia from March to April 2020 were reviewed. The following data were recorded: age, temperature, clinical presentation, oral mucosa lesions, taste alteration and cutaneous lesions.
RESULTS: The medical records of twenty-seven pediatric patients (mean age 4,2 years + 1,7) were analyzed. The clinical presentation of the disease mainly included elevated body temperature and cough. The following oral lesions were recorded: oral pseudomembranous candidiasis (7.4 %), geographic tongue (3.7%), coated tongue (7.4 %) and hyperaemic pharynx (37 %). Taste alteration was reported by 3 patients. Six patients presented cutaneous flat papular lesions.
CONCLUSIONS: As for our paediatric sample, COVID-19 resulted to be associated with non-specific oral and cutaneous manifestations.

Entities:  

Mesh:

Year:  2021        PMID: 33772567      PMCID: PMC8412440          DOI: 10.4317/medoral.24461

Source DB:  PubMed          Journal:  Med Oral Patol Oral Cir Bucal        ISSN: 1698-4447


Introduction

The current outbreak of the novel Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) constitutes a public health emergency of global concern (1-2). This is the third coronavirus to emerge in the human population. It was preceded by the Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) outbreak in 2002 and the Middle East Respiratory Syndrome Coronavirus (MERS-CoV) outbreak in 2012. Symptoms of coronavirus disease 2019 (COVID-19) in adults include fever, cough and acute respiratory disease, with severe cases leading to pneumonia, kidney failure and even death. Reports on paediatric patients are mainly of Chinese origin and suggest a milder course of COVID-19 in children (3-4). Compared to other respiratory viruses, children seem to have a lower risk of infection since the majority of these illnesses in children were mild or asymptomatic, with few-recorded childhood fatalities attributed to COVID -19 (5). According to Swann, the most common symptoms were fever, cough, nausea/vomiting and shortness of breath. As fever and rhinorrhoea were less common increasing with age, on the contrary nausea and vomiting, abdominal pain, headache and sore throat showed an increasing trend (6). An interesting outlook during the COVID outbreak was the potential association between Kawasaki disease (KD) and COVID-19. KD can display changes in the lips and in the oral cavity, such as erythema, dryness, fissuring, peeling, cracking, lips prone to bleedings and “strawberry tongue.” As a matter of fact an Italian observational study on paediatric patients by Verdoni et al. (7) showed that, during the COVID-19 outbreak, KD had at least a 30 times higher monthly incidence compared to those of the last 5 years in the Bergamo district. Taste alteration was found to be the most reported symptom and thus described oral manifestation during a COVID-19 infection, with a range of prevalence between 5.6% and 92.64% (8-9). Paderno et al. (10) reported that in 11% of cases, patients expressed taste alteration as their first symptom of COVID-19 infection, whereas other authors described it as the only symptom detected during the illness itself (11-13). As of now, few studies cite the presence of oral lesions during COVID-19 infection, especially in children. Oral mucosal lesions correlated to COVID-19 have been reported in some Spanish patients, as case series (14-15). In particular, there were a few cases of diffuse oral pain, desquamative gingivitis, ulcers and blisters in adults. Oral manifestations were also reported to be associated with dermatological alterations i.e. erythema multiforme-like eruption. However, no causal association between COVID-19 and cutaneous lesions has been officially demonstrated thus far. Moreover a significant number of cases of chilblains have been observed, mainly in adolescents and young adults with no or mild symptoms compatible with SARS-CoV-2 infection. Therefore a correlation between chilblains and COVID-19 has been suspected, but the pathophysiology of these lesions is still widely debated (16-17). The purpose of this retrospective study was to investigate the prevalence and characteristics of oral and cutaneous lesions in a group of Italian children affected by COVID-19.

Material and Methods

This retrospective study was completed in Brescia, one of the Italian cities with the highest number of affected patients. All the medical records of children with COVID-19 admitted to the Pediatric Clinic- ASST Spedali Civili of Brescia from March to April 2020 were reviewed. Inclusion criteria were: (a) pediatric patients (aged 0-14 years old) (b) laboratory evidence of COVID-19 infection (c) signed informed consent. From each patient’s medical record, the following data were recorded: age, COVID-19 family history, temperature, clinical presentation (cough, rhinorrhoea, breathing difficulty, and saturation), oral mucosa lesions, taste alterations (reported by the child) and cutaneous lesions. This study was approved by the Ethics Committee of ASST-Spedali Civili of Brescia (N. 4055) and followed the Declaration of Helsinki. Written consent was obtained from the caregivers of the patients. The data were inserted on an excel spreadsheet. Descriptive analysis was used for demographic and clinical data.

Results

A total of 27 children’s medical records were analyzed: patients’ age ranged from 3 months to 14 years of age (mean age 4,2 years + 1,7 years). 17 of the 27 cases (63%) presented a COVID-19 positive family history. Elevated body temperature (>37°C) was the most frequent clinical finding. Most of the patients (15/27, 55.5%) presented a body temperature >38°C while others (10/27 cases, 37%) showed mild febrile conditions (body temperature: 37.5°-38°C). The first reported clinical symptoms included mainly cough (10/27 cases; 37%) and rhinorrhoea (7/27 cases; 25.9%), while difficulty in breathing was rarely registered (5/27 cases; 18.5%), all patients’ oxygen saturation levels constantly remained above 92%. The following oral lesions were recorded: oral pseudomembranous candidiasis (2/27 cases; 7.4%), geographic tongue (1/27 case; 3.7%), coated tongue (2/27 cases; 7.4%) and hyperaemic pharynx (10/27 cases; 37%). Taste alteration was reported by 3 patients (11.1%). Six patients presented cutaneous flat papular lesions (22.2%). The results are summarized in Table 1.
Table 1

Demographic and clinical features of the sample (n=27).

Discussion

The clinical presentation of COVID-19 in our paediatric cohort did not differ from that of other studies in paediatric patients (3-4). If compared to adults, the children’s clinical presentations resulted to be overall milder, in terms of cough, breathing difficulty, oxygen saturation, fatigue and abdominal pain, in agreement with Literature (18). A wide spectrum of signs and symptoms were reported in association with novel COVID-19; however, few studies described oral clinical manifestations in patients diagnosed with this disease, none in children as far as we know. Jimenez-Cauhe et al. (14) reported observing erythema multiforme (EM)-like oral and cutaneous lesions in 3 hospitalized women (mean age 66.75 years) who showed palatal macules and petechiae. The Authors suggested that the EM-like exanthema might have been another pattern of infection associated with COVID-19 or perhaps a drug-related reaction. Martín Carreras-Presas et al. (15) reported 3 cases of vesicle-bullous lesions associated with COVID-19. All cases presented ulcers or blisters in the oral cavity, appearing and advancing during the isolation period. In two of these cases, lesions affected keratinized tissue, as seen in herpes simplex lesions; in the third case, oral lesions affected both keratinized and non-keratinized tissue and were more compatible with EM. However, it must be considered that the available data on oral lesions could have been underreported, reasonably prioritizing the treatment of the respiratory distress first. In our paediatric cohort, we found the following oral lesions: hyperaemic pharynx, oral pseudomembranous candidiasis, geographic tongue and coated tongue. The most frequent oral lesion resulted to be hyperaemic pharynx. Acute pharyngitis is an inflammatory syndrome of the pharynx and/or tonsils caused by several different groups of microorganisms. Numerous viruses can cause viral pharyngitis. Pharyngitis can be part of a generalized upper respiratory tract infection or a specific infection localized in the pharynx. Therefore, a mild case of pharyngitis can be considered a finding consistent with the viral origin of COVID-19. Two patients showed oral pseudomembranous candidiasis, confirmed by a swab of the lesions. In healthy subjects, the percentage of oral candidiasis reported in literature varies from 0.80% to 3.7% in school-age children (19-21). In the present study, candidiasis rates were higher, possibly because newborns and infants were part of our cohort. Two patients presented a coated tongue. The papillary structure of the tongue dorsum forms a unique ecological site. Its large surface area favours the accumulation of oral debris and microorganisms. Tongue coating is in fact made up of bacteria, large amounts of desquamated epithelial cells released from the oral mucosa, leukocytes from periodontal pockets, blood metabolites and different nutrients. Microscopic research on the tongue's ultrastructure has shown that the formation of tongue coating is associated with the rate of multiplication of epithelial cells. During a viral infection, a coated tongue can be a frequent and reversible occurrence, due to the temporary pH change of the oral cavity. This transient variation can reduce the rate of epithelial desquamation, thus, favouring the accumulation of oral debris and microorganisms (20-22). One patient had a geographic tongue, which, according to the mother, appeared concurrently with the high fever. The etiopathogenesis of the geographic tongue is still unclear. Several authors have reported a higher prevalence in young children (0-6 years of age) and hypothesized that non-genetic multifactorial factors, including viral infections, could be involved (19-21). One of the most described oral symptoms in Literature was taste alteration. In most cases of viral upper respiratory infections, the experience of eating food and perceiving flavour can be blunted as a result of rhinitis and nasal obstruction. Whereas during a COVID-19 infection, a loss of smell or taste seems to be a neural process due to viral insult and most commonly results in hyposmia or hypogeusia (24-25). In some cases, anosmia, dysgeusia and hypogeusia appeared to be early presenting symptoms of COVID-19 prior to respiratory symptoms. However, apart from one single study (25) which used a validated questionnaire, we must take into consideration the fact that most of these documented symptoms were predominantly self-reported, as in our retrospective study. In our sample, 3 children experienced taste alterations and loss of appetite. Nevertheless this data is not reliable, and some symptoms have probably been under-reported, most likely due to the average age of the sample (mainly infants), which obviously prevented them from reporting their symptoms. In addition, another factor worth considering is the impossibility of performing gustatory tests in a retrospective study such as ours. Cutaneous manifestations in patients with COVID-19 infection are being more and more frequently reported. Several patterns have been described since the initial report by Recalcati (26), including erythematous maculopapular, urticarial, chickenpox-like, purpuric peri-flexural, transient livedo reticularis and acro-ischemic or chilblain-like lesions. In a recent Chinese review, a rash was observed in 0.2% of cases (27). Other studies described dermatologic involvement, including lesions that range from affectation of the hands and feet to vasculitis, rash, urticaria, and varicella-like lesions (28). In our paediatric sample, six children presented cutaneous lesions i.e. non-itchy confluent flat papular lesions of the face and limbs, without any associated lesions in the inner part of the oral cavity. Considering these findings, it is possible that COVID-19 provokes common viral exanthematous lesions, such as those caused by Adenoviruses, Enteroviruses, Influenza A or Para-influenza type 3. Although there are numerous publications about “chilblains”, “pseudo-chilblains”, “chilblain-like lesions”, “covid-toes” or “acral ischemic lesions”, our sample did not show any of these symptoms (29). Based on our results, we can speculate that there are no specific oral manifestations in children during a COVID-19 infection. It is instead possible to find lesions consistent with those typically found during a common influenza virus infection.
  29 in total

1.  Epidemiology of COVID-19 Among Children in China.

Authors:  Yuanyuan Dong; Xi Mo; Yabin Hu; Xin Qi; Fan Jiang; Zhongyi Jiang; Shilu Tong
Journal:  Pediatrics       Date:  2020-03-16       Impact factor: 7.124

2.  Cutaneous manifestations in COVID-19: a first perspective.

Authors:  S Recalcati
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-05       Impact factor: 6.166

3.  Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study.

Authors:  Jerome R Lechien; Carlos M Chiesa-Estomba; Daniele R De Siati; Mihaela Horoi; Serge D Le Bon; Alexandra Rodriguez; Didier Dequanter; Serge Blecic; Fahd El Afia; Lea Distinguin; Younes Chekkoury-Idrissi; Stéphane Hans; Irene Lopez Delgado; Christian Calvo-Henriquez; Philippe Lavigne; Chiara Falanga; Maria Rosaria Barillari; Giovanni Cammaroto; Mohamad Khalife; Pierre Leich; Christel Souchay; Camelia Rossi; Fabrice Journe; Julien Hsieh; Myriam Edjlali; Robert Carlier; Laurence Ris; Andrea Lovato; Cosimo De Filippis; Frederique Coppee; Nicolas Fakhry; Tareck Ayad; Sven Saussez
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-04-06       Impact factor: 2.503

4.  Clinical Characteristics of Coronavirus Disease 2019 in China.

Authors:  Wei-Jie Guan; Zheng-Yi Ni; Yu Hu; Wen-Hua Liang; Chun-Quan Ou; Jian-Xing He; Lei Liu; Hong Shan; Chun-Liang Lei; David S C Hui; Bin Du; Lan-Juan Li; Guang Zeng; Kwok-Yung Yuen; Ru-Chong Chen; Chun-Li Tang; Tao Wang; Ping-Yan Chen; Jie Xiang; Shi-Yue Li; Jin-Lin Wang; Zi-Jing Liang; Yi-Xiang Peng; Li Wei; Yong Liu; Ya-Hua Hu; Peng Peng; Jian-Ming Wang; Ji-Yang Liu; Zhong Chen; Gang Li; Zhi-Jian Zheng; Shao-Qin Qiu; Jie Luo; Chang-Jiang Ye; Shao-Yong Zhu; Nan-Shan Zhong
Journal:  N Engl J Med       Date:  2020-02-28       Impact factor: 91.245

5.  Oral vesiculobullous lesions associated with SARS-CoV-2 infection.

Authors:  Carmen Martín Carreras-Presas; Juan Amaro Sánchez; Antonio Francisco López-Sánchez; Enric Jané-Salas; Maria Luisa Somacarrera Pérez
Journal:  Oral Dis       Date:  2020-05-29       Impact factor: 4.068

6.  Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study.

Authors:  Olivia V Swann; Karl A Holden; Lance Turtle; Louisa Pollock; Cameron J Fairfield; Thomas M Drake; Sohan Seth; Conor Egan; Hayley E Hardwick; Sophie Halpin; Michelle Girvan; Chloe Donohue; Mark Pritchard; Latifa B Patel; Shamez Ladhani; Louise Sigfrid; Ian P Sinha; Piero L Olliaro; Jonathan S Nguyen-Van-Tam; Peter W Horby; Laura Merson; Gail Carson; Jake Dunning; Peter J M Openshaw; J Kenneth Baillie; Ewen M Harrison; Annemarie B Docherty; Malcolm G Semple
Journal:  BMJ       Date:  2020-08-27

7.  SARS-CoV-2 Infection in Children.

Authors:  Xiaoxia Lu; Liqiong Zhang; Hui Du; Jingjing Zhang; Yuan Y Li; Jingyu Qu; Wenxin Zhang; Youjie Wang; Shuangshuang Bao; Ying Li; Chuansha Wu; Hongxiu Liu; Di Liu; Jianbo Shao; Xuehua Peng; Yonghong Yang; Zhisheng Liu; Yun Xiang; Furong Zhang; Rona M Silva; Kent E Pinkerton; Kunling Shen; Han Xiao; Shunqing Xu; Gary W K Wong
Journal:  N Engl J Med       Date:  2020-03-18       Impact factor: 91.245

8.  Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study.

Authors:  Haiyan Qiu; Junhua Wu; Liang Hong; Yunling Luo; Qifa Song; Dong Chen
Journal:  Lancet Infect Dis       Date:  2020-03-25       Impact factor: 71.421

9.  Study Protocol for an Online Questionnaire Survey on Symptoms/Signs, Protective Measures, Level of Awareness and Perception Regarding COVID-19 Outbreak among Dentists. A Global Survey.

Authors:  Guglielmo Campus; Marcela Diaz-Betancourt; Maria Grazia Cagetti; Joana C Carvalho; Thiago S Carvalho; Javier F Cortés-Martinicorena; James Deschner; Gail V A Douglas; Rodrigo Giacaman; Vita Machiulskiene; David J Manton; Daniela P Raggio; Francisco Ramos-Gomez; Ruxandra Sava-Rosianu; Natalia S Morozova; Gianrico Spagnuolo; Ana Vukovic; Thomas G Wolf
Journal:  Int J Environ Res Public Health       Date:  2020-08-03       Impact factor: 3.390

Review 10.  Cutaneous Manifestations of COVID-19: An Evidence-Based Review.

Authors:  Giulia Daneshgaran; Danielle P Dubin; Daniel J Gould
Journal:  Am J Clin Dermatol       Date:  2020-10       Impact factor: 6.233

View more
  5 in total

Review 1.  Oral mucosal lesions in patients with COVID-19: a systematic review.

Authors:  N Bhujel; K Zaheer; R P Singh
Journal:  Br J Oral Maxillofac Surg       Date:  2021-06-25       Impact factor: 1.651

2.  Oral Manifestations of COVID-19 in Hospitalized Patients: A Systematic Review.

Authors:  Giulia Orilisi; Marco Mascitti; Lucrezia Togni; Riccardo Monterubbianesi; Vincenzo Tosco; Flavia Vitiello; Andrea Santarelli; Angelo Putignano; Giovanna Orsini
Journal:  Int J Environ Res Public Health       Date:  2021-11-27       Impact factor: 3.390

Review 3.  Oral Manifestations in SARS-CoV-2 Positive Patients: A Systematic Review.

Authors:  Kacper Nijakowski; Sylvia Wyzga; Nisha Singh; Filip Podgórski; Anna Surdacka
Journal:  J Clin Med       Date:  2022-04-14       Impact factor: 4.964

Review 4.  Oral Lesions Associated with COVID-19 and the Participation of the Buccal Cavity as a Key Player for Establishment of Immunity against SARS-CoV-2.

Authors:  Jose Roberto Gutierrez-Camacho; Lorena Avila-Carrasco; Maria Calixta Martinez-Vazquez; Idalia Garza-Veloz; Sidere Monserrath Zorrilla-Alfaro; Veronica Gutierrez-Camacho; Margarita L Martinez-Fierro
Journal:  Int J Environ Res Public Health       Date:  2022-09-09       Impact factor: 4.614

Review 5.  Prevalence of oral manifestations in COVID-19: A systematic review.

Authors:  Preeti Sharma; Sangeeta Malik; Vijay Wadhwan; Suhasini Gotur Palakshappa; Roli Singh
Journal:  Rev Med Virol       Date:  2022-03-10       Impact factor: 11.043

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.